Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treatment of ischemic heart disease: Future research needs prioritization
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference77 articles.
1. Heart disease and stroke statistics—2010 update: a report from the American Heart Association;Lloyd-Jones;Circulation,2010
2. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation Study Investigators;Ambrosioni;N Engl J Med,1995
3. A clinical trial of the angiotensin-converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction;Køber;N Engl J Med,1995
4. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both;Pfeffer;N Engl J Med,2003
5. Comparative effectiveness of angiotensin converting enzyme inhibitors or angiotensin II receptor blockers added to standard medical therapy for treating stable ischemic heart disease;Coleman,2009
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Review of the Protective Mechanism of Curcumin on Cardiovascular Disease;Drug Design, Development and Therapy;2024-01
2. Cardiovascular Protection with a Long-Acting GLP-1 Receptor Agonist Liraglutide: An Experimental Update;Molecules;2023-02-01
3. Future research prioritization in cardiac resynchronization therapy;American Heart Journal;2020-05
4. Anti-fibrotic effects of curcumin and some of its analogues in the heart;Heart Failure Reviews;2019-09-11
5. Liraglutide attenuates cardiac remodeling and improves heart function after abdominal aortic constriction through blocking angiotensin II type 1 receptor in rats;Drug Design, Development and Therapy;2019-08
Liraglutide attenuates cardiac remodeling and improves heart function after abdominal aortic constriction through blocking angiotensin II type 1 receptor in rats
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3